Publications by authors named "Ro Wickramasinghe"

Claim this Profile
T
Topical TrkA Kinase Inhibitor CT327 is an Effective, Novel Therapy for the Treatment of Pruritus due to Psoriasis: Results from Experimental Studies, and Efficacy and Safety of CT327 in a Phase 2b Clinical Trial in Patients with Psoriasis.
David Roblin, Gil Yosipovitch, Brent Boyce, John Robinson, James Sandy, Ro Wickramasinghe

Acta Derm Venereol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pruritus severity in patients with psoriasis is not correlated with psoriasis disease severity.
David Roblin, Ro Wickramasinghe, Gil Yosipovitch

J Am Acad Dermatol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis